Opexa Therapeutics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7.01M

Opexa Therapeutics General Information

Description

Provider and developer of patient-specific cellular therapies intended for the treatment of autoimmune diseases. The company's personalized cellular immunotherapy treatment is in late stage clinical development targeting both Secondary Progressive and Relapsing Remitting MS, aligning the interests of patients, employees and shareholders.

Contact Information

Formerly Known As
Sportan United Industries, PharmaFrontiers
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Corporate Office
  • 2635 Technology Forest Boulevard
  • The Woodlands, TX 77381
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Opexa Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 19-Sep-2017 $7.01M 000.00 00.000 Completed Profitable
9. 2PO 07-Aug-2013 0000 000.00 000.00 Completed Profitable
8. Debt - General 15-Feb-2013 00000 00.000 Completed Profitable
7. PIPE 16-Nov-2012 00.000 Completed Profitable
6. PIPE 00.000 Completed Profitable
5. Convertible Debt 01-May-2009 00.000 00.000 Completed Profitable
4. PIPE 13-Apr-2008 000 000 Completed Profitable
3. Accelerator/Incubator 01-Jan-2008 Completed Profitable
2. IPO 14-Apr-2004 Completed Profitable
1. Early Stage VC 01-Feb-2001 Completed Profitable
To view Opexa Therapeutics’s complete valuation and funding history, request access »

Opexa Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider and developer of patient-specific cellular therapies intended for the treatment of autoimmune diseases. The com
Biotechnology
The Woodlands, TX
000.00
00.000 0000-00-00
000000&0 000.00

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qu
0000000000000
San Diego, CA
0000 As of 0000
00000
00000000 00000

000000

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Opexa Therapeutics Competitors (57)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurocrine Biosciences Formerly VC-backed San Diego, CA 0000 00000 00000000 00000
Intellia Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
Sorrento Therapeutics Formerly VC-backed San Diego, CA 000 00000 0000000000.
MorphoSys Formerly PE-Backed Planegg, Germany 000 00000 000000&0 00000
You’re viewing 5 of 57 competitors. Get the full list »

Opexa Therapeutics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BCM Ventures Venture Capital Minority 000 0000 000000 0
Diker Management Hedge Fund Minority 000 0000 000000 0
Houston Technology Center Accelerator/Incubator Minority 000 0000 000000 0
Lehman Brothers Other Private Equity Minority 000 0000 000000 0
Lincoln Park Capital Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Opexa Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Acer Therapeutics 19-Sep-2017 0000000 00 Drug Discovery
To view Opexa Therapeutics’s complete acquisitions history, request access »

Opexa Therapeutics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Acer Therapeutics 19-Sep-2017 0000000 000000 Completed
  • 00000 000000000000
To view Opexa Therapeutics’s complete exits history, request access »

Opexa Therapeutics FAQs

  • When was Opexa Therapeutics founded?

    Opexa Therapeutics was founded in 2001.

  • Who is the founder of Opexa Therapeutics?

    Jingwu Zhang and Michael Redman are the founders of Opexa Therapeutics.

  • Where is Opexa Therapeutics headquartered?

    Opexa Therapeutics is headquartered in The Woodlands, TX.

  • What industry is Opexa Therapeutics in?

    Opexa Therapeutics’s primary industry is Biotechnology.

  • Is Opexa Therapeutics a private or public company?

    Opexa Therapeutics is a Private company.

  • What is the current valuation of Opexa Therapeutics?

    The current valuation of Opexa Therapeutics is 00.000.

  • What is Opexa Therapeutics’s current revenue?

    The current revenue for Opexa Therapeutics is 000000.

  • How much funding has Opexa Therapeutics raised over time?

    Opexa Therapeutics has raised $22.9M.

  • Who are Opexa Therapeutics’s investors?

    BCM Ventures, Diker Management, Houston Technology Center, Lehman Brothers, and Lincoln Park Capital are 5 of 6 investors who have invested in Opexa Therapeutics.

  • Who are Opexa Therapeutics’s competitors?

    Neurocrine Biosciences, Intellia Therapeutics, NexImmune, Sorrento Therapeutics, and MorphoSys are some of the 57 competitors of Opexa Therapeutics.

  • When was Opexa Therapeutics acquired?

    Opexa Therapeutics was acquired on 19-Sep-2017.

  • Who acquired Opexa Therapeutics?

    Opexa Therapeutics was acquired by Acer Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »